Healthcare Triangle Inc

Healthcare Triangle Inc

HCTI · NASDAQ · Healthcare / Health Information Services

3.66USD-0.08 (-2.14%)

Price History

Full chart

Market Stats

Previous Close3.74
Open4.00
Day Range3.51 – 4.00
52-Week Range0.65 – 223.20
Volume19.09K
Market Cap10.69M
P/E (TTM)0.00
Forward P/E0.00
EPS-5.78
Dividend Yield0.00%
Beta1.09
50-Day Avg1.10
200-Day Avg13.63

About

Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain infrastructure; and Cybersecurity navigator. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery capabilities on public cloud. It also serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. David Ayanoglou
  • Employees40
  • Headquarters7901 Stoneridge Drive, Pleasanton, CA, United States, 94588, USA
  • Websitehttps://www.healthcaretriangle.com

Leadership

  • Mr. David AyanoglouChief Financial Officer · b. 1980
  • Ms. Sujatha RameshPrincipal Executive Officer (SEC), COO & Executive Director · b. 1971
  • Ms. Shelly PierceHead of Human Resources & Talent Acquisition
  • Mr. Jason MudrickHead of Practice of Epic · b. 1984
  • Ms. Karen HughesHead of Practice of Meditech
  • Ronald BetetaHead of Customer Success

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.28K29.37K5.82K232.36K28.74M31.34M35.27M45.89M33.20M11.70M13.89M
Growth (%)--21.22%-80.20%+3895.86%+12267.33%+9.06%+12.54%+30.10%-27.64%-64.77%+18.77%
Cost of Revenue37.65K1.99K4.61K134.32K23.66M23.56M24.75M34.59M26.43M8.81M12.00M
Gross Profit-36927.38K1.21K98.03K5.07M7.78M10.52M11.29M6.78M2.89M1.89M
Gross Margin-0.99%93.21%20.72%42.19%17.65%24.83%29.83%24.62%20.41%24.71%13.61%
Operating Expense3.10M3.76M2.98M1.39M3.40M6.61M15.88M27.62M14.47M7.64M11.68M
Operating Income-3.10M-3.73M-2.98M-1.29M1.67M1.18M-5.36M-16.32M-7.70M-4.75M-9.79M
Operating Margin-8324.48%-12696.48%-51186.29%-554.54%5.81%3.75%-15.19%-35.57%-23.18%-40.62%-70.47%
EBITDA----2.45M1.98M-3.94M-10.70M-6.12M-3.85M-8.20M
EBITDA Margin----8.51%6.32%-11.16%-23.31%-18.42%-32.96%-59.06%
Net Income-5.81M-5.83M-6.73M-4.58M1.17M2.35M-5.95M-14.36M-8.69M-5.97M-9.48M
Net Income Margin-15588.04%-19864.78%-115757.47%-1970.20%4.08%7.51%-16.87%-31.29%-26.16%-51.03%-68.22%
R&D00001.01M1.74M5.26M8.14M799.00K429.00K536.00K
R&D as % of Total Revenue0.00%0.00%0.00%0.00%3.53%5.56%14.91%17.74%2.41%3.67%3.86%
Interest Expense000052.58K78.65K567.00K212.00K968.00K1.21M567.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.18%0.25%1.61%0.46%2.92%10.37%4.08%

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets444.94K2.14M1.17M2.12M8.25M11.11M24.61M13.26M6.86M1.96M22.74M
Total Liabilities6.51M7.71M7.83M9.88M6.28M6.78M8.48M7.22M8.25M7.08M12.79M
Total Equity-6.06M-5.58M-6.66M-7.75M1.97M4.33M16.14M6.04M-1.39M-5.11M9.98M
Cash0023.89K28974.83K1.40M1.77M1.34M1.23M20.00K7.63M
Total Debt-----754.40K3.45M2.69M3.88M2.65M10.74M
Net Debt-----974.83K-648.30K1.68M1.34M2.65M2.63M3.11M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-495.48K-394.13K-513.63K-971.32K3.97M-734.67K-7.11M-5.35M-2.15M-1.08M-16.52M
Investing Cash Flow-12.00K-12.00K-12.00K-5.00K-3.65M-477.46K-7.63M-1.13M-12.00K-13.00K-1.75M
Financing Cash Flow495.48K394.13K549.52K952.45K1.64M1.64M15.11M6.06M2.06M-133.00K25.88M
Capital Expenditure0005.00K3.65M33.13M1.13M12.00K13.00K6.00K
Free Cash Flow----3.97M-734.67K-10.24M-6.49M-2.16M-1.08M-16.52M
Dividends Paid0000-----00
FCF to OCF----100.00%100.00%144.00%121.18%100.56%100.00%100.00%
Dividend Paid to FCF---------0.00%0.00%

Earnings

Report DateSep 30, 2010Mar 31, 2014Jun 30, 2014Sep 30, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Oct 14, 2021Mar 8, 2022May 16, 2022Aug 8, 2022Nov 10, 2022Mar 28, 2023May 9, 2023Aug 10, 2023Nov 13, 2023Mar 18, 2024May 20, 2024Aug 7, 2024Nov 29, 2024Mar 31, 2025May 20, 2025Aug 14, 2025Nov 13, 2025Dec 31, 2025Apr 15, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate---------------7469.92-7469.92-5975.93-0.04-0.04-0.03-----0.00---13.20-12.00-12.00-3.43-0.97
EPS Actual-175.97-21.42-10.23-14.08-9.13-0.01-0.01-0.00-0.60-0.100.16-0.000.05-0.12-8515.71-1493.98-10457.89-0.13-0.08-0.42-0.46-1.24-0.42-70.72-54.89-0.24-0.17-0.58-25.20-18.50-18.50-1.56-
Surprise---------------14.00%80.00%-75.00%-225.00%-100.00%-1308.00%---------90.91%-54.17%-54.17%54.52%-
Timing-------------After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-----Pre-market-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap10.69M
Enterprise Value49.90M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.42
Price / Book0.56
EPS-5.78
Book Value11.71
Revenue (TTM)25.67M
Gross Profit (TTM)5.53M
EBITDA-13.09M
Profit Margin-66.30%
Operating Margin-44.28%
Return on Equity-57.41%
Return on Assets-20.87%
Shares Outstanding14.64M
Shares Float14.97M
Beta1.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 3.15
  • Strong Buy
    1

Ownership Breakdown

Institutions
0.36%
Insiders
0.00%
Retail / Other
99.64%

Top Institutional Holders

  • UBS Group AG
    40.72K0.27%
  • Morgan Stanley - Brokerage Accounts
    20.47K0.14%
  • Bank of Montreal
    20.00K0.13%
  • Virtu Financial LLC
    14.62K0.10%
  • Geode Capital Management, LLC
    12.60K0.08%
  • BMO Capital Markets Corp.
    10.00K0.07%
  • Vanguard Capital Management, LLC
    8590.01%
  • Tower Research Capital LLC
    7940.01%
  • Vanguard Fiduciary Trust Co
    4820.00%
  • State Street Corp
    00.00%
  • Citigroup Inc
    00.00%
  • Meteora Capital, LLC
    00.00%
  • Bank of America Corp
    00.00%
  • BNP Paribas Arbitrage, SA
    70.00%
  • Danske Bank A/S.
    10.00%

Top Fund Holders

  • Fidelity Extended Market Index
    10.90K0.07%
  • Fidelity Series Total Market Index
    8590.01%
  • Fidelity Total Market Index
    1400.00%

Stock Splits

  • Oct 26, 20261:20
  • Feb 10, 20261:60
  • Aug 1, 20251:249
  • May 26, 20231:10